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immunoglobulinAbstract The initiating event in multiple sclerosis (MS) pathogenesis is not known yet. However,
in general, breakdown of the blood-brain barrier (BBB) and subsequent inﬁltration of immune cells
into the central nervous system (CNS) has been thought to be the main initiating event. Nonethe-
less, the mechanism by which the BBB gets disrupted and allows immune cells to inﬁltrate into the
CNS is not fully understood. Evidence indicates that prior to cellular inﬁltration, over passing
peripherally generated cross-reactive immunoglobulin G (IgG) through the transiently permeable
BBB during systemic inﬂammation, hypoxia, hyperthermia, transient hypertension or acute stresses
may cause CNS inﬂammation, BBB breakdown and then initiation of MS disease. Here, we discuss
the possible detailed mechanisms that may be involved in cross-reactive IgG-mediated MS autoim-
munity.
ª 2013 Tehran University of Medical Sciences. Published by Elsevier Ltd.D license.Introduction
Multiple sclerosis (MS) is characterised as a demyelinating
autoimmune disease of the central nervous system (CNS)mediated by inﬂammatory responses of immune cells
(TCD4 and B cells) towards the myelin components of neu-
rons. Destruction of neuronal myelin sheaths following mye-
lin-speciﬁc cytotoxic immune responses causes partial or
Figure 1 Schematic representation for the proposed role of auto-
reactive IgG in initiation of MS. (a) Intact BBB restricts crossing
of auto-reactive IgG into CNS. (b) Transient increase in BBB
permeability allows auto-reactive IgG to reach into CNS and
opsonize neuronal myelin sheath. (c) Even though BBB is repaired
but Fc-receptor mediated recruitment and activation of microglial
cells leads to phagocytosis and destruction of myelin sheath. (d)
CNS inﬂammation mediated by inﬂammatory responses of
microglial cells causes to BBB impairment. (e) Impaired BBB
allows immune cells to recruit into CNS in response to chemokines
released from inﬂamed foci.
64 A. Mokarizadeh et al.complete failures in signal conduction and neuro-physical
disabilities [1].
Even though most of the studies have considered the broken
blood–brain barrier (BBB) and subsequent CNS-inﬁltrated
TCD4 and B cells as the main starters for the onset of the dis-
ease, the main cause of the disease is not known yet. However,
genetic and environmental factors, some infectious diseases,
molecular mimicry, oxidative stresses and nuclear, DNA and
mitochondrial damages have been described as potent risk
factors [2,3]. Recently, many of the ongoing studies have
focussed on molecular mimicry and cross-reactivity as a potent
pathogenic mechanism of MS disease. Molecular or antigenic
mimicry is deﬁned as similar structures or determinants (either
in linear amino acid sequences or in a conformational ﬁt)
shared by molecules expressed by different genes [4]. Moreover,
molecular mimicry may be observed in agent-induced cell
injuries that get converted to co-self-antigens or releasing of
self-antigens. However, an antigenic or molecular similarity
between host cells and exogenous agents can evoke the genera-
tion of cross-reactive effector cells or antibodies that may cause
destruction of both host cell/tissue and exogenous agent [4–6].
Recently, the antigenic similarity between myelin antigens
and variety of infectious agents and allergens has been well
demonstrated.
Hypothesis
Myelin oligodendrocyte glycoprotein (MOG), myelin basic
protein (MBP) and myelin proteolipid protein (PLP) are found
to be target neuronal myelin antigens for both humoral and
cellular CNS-recruited immune responses. Although MS is
widely thought to be a TCD4 cell-mediated autoimmunity pri-
marily, several pieces of evidence have indicated the signiﬁcant
role of humoral immunity in the disease process. The role of
humoral immunity in MS pathogenesis has been attributed
to intrathechal antibody synthesis and oligoclonal expansion
of inﬁltrated B cells [7]. Moreover, the mechanism by which
immune cells can inﬁltrate into the CNS is not fully under-
stood, but in general, the broken or disrupted BBB is thought
to be a key initiating event [6]. Even though several studies
proposed the involvement of a cross-reaction between myelin
and infectious agents in MS pathogenesis, there is no study
that reveals the possible role of cross-reactive immunoglobulin
Gs (IgGs) in the initiation of MS disease. Even though low
permeability of intact BBB to IgGs restricts their penetration
into the CNS, the augmented BBB permeability during
systemic infections, inﬂammations, transient hypertension,
hypoxia, hyperthermia or acute stresses may highlight their
possible initiating role in MS pathogenesis (Fig. 1).
Evaluation of hypothesis
The present hypothesis should be examined in experimental
autoimmune encephalomyelitis (EAE) in an animal model of
MS disease. Indeed, this model has helped scientists identify
putative mechanisms involved in MS pathogenesis.
EAE can be induced in female 6–8-week-old C57BL/6
mice (a susceptible strain to EAE) by co-immunisation with
myelin oligodendrocyte glycoprotein (MOG35-55) peptide in
complete Freund’s adjuvant and pertussis toxin [8]. After
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symptoms, mice should be euthanised by decapitation and
sera obtained from blood samples. MOG-speciﬁc Igs also
can be isolated from supernatants of MOG-primed splenic
mononuclear cells (MNCs). Alternatively, generation of
MOG cross-reactive Igs can be induced by subcutaneous
immunisation of C57BL/6 mice with butyrophilin milk
protein emulsiﬁed in CFA [9]. Collected sera or supernatant
samples should be concentrated, puriﬁed for Igs and then
should be labelled with biotin [10,11]. Healthy female 6–8-
week-old mice (C57Bl/6) should be immunised intravenously
(tail vein) with biotin-labelled Igs at several time points.
Simultaneously, at the same times, the BBB can be left intact
(as negative control) or permeability of the BBB can be
facilitated by intra-peritoneal administration of pertussis
toxin and/or cocaine (as positive control) [8,12], inﬂamma-
tory cytokine-rich EAE serum (as inﬂammatory condition),
adrenaline [11], (as the transient hypertension) [13] or by
exposing the animal to hypobaric hypoxia (equivalent to
0.5 atm) at 37 C (as hypoxic condition) [14–16] in separate
groups. Immunised mice should be monitored daily for
EAE symptoms. Brain and spinal cord tissues should be
harvested from both EAE-established- and non-affected mice.
After preparation of histopathological sections, using the
avidin–biotin cytochemichal detection system, haematoxylin
and eosin (H&E) and Luxol fast blue staining methods, the
CNS-efﬂuxed antibodies, inﬁltrated immune cells and demye-
linated regions should be probed in sections. Detection of
ﬂuorescein-labelled Igs and demyelinated regions in the
CNS with or without obvious clinical symptoms will conﬁrm
the accuracy of the hypothesis.
Discussion
Molecular mimicry has been described as a potentially pos-
sible mechanism involved in the pathogenesis of MS and
other autoimmune diseases. Some of the viruses (human her-
pes virus-6 and Epstein–Barr virus), bacteria (Acinetobacter
sp., Pseudomonas aeruginosa) and even allergens (milk pro-
tein butyrophilin) have shown to share the same epitopes
with myelin [17–20]. Moreover, the elevated titres of viral-
(measles virus envelope, haemolysin and haemagglutinin
antigens, Epstein–Barr virus capsid antigens and nucleus
antigen, rubella virus haemagglutinin and human herpes
virus-6 antigens) and bacterial- (Chlamydia pneumoniae,
Mycoplasma sp. and Borrelia burgdorferi) speciﬁc antibodies
found in the serum of MS patients, are consistent with these
ﬁndings [21–25] Moreover, recently, responsibility of normal
gut bacteria for antigenic mimicry in MS pathogenesis has
been strongly suggested [26]. This would clearly explain
the cause of absent epidemiological evidence for infectious
agents in some MS patients. Besides, the increased incidence
of MS in females may be explained by the fact that female
individuals generally exhibit more robust antibody responses
and also produce more autoreactive antibodies than male
individuals do [27]. This obvious fact can clearly allocate
an important initiating role to autoreactive antibodies in
the pathogenesis of MS and other autoimmune diseases.
Earlier-mentioned evidence indicates frequency of
generation of myelin cross-reactive Igs upon exposure of
the immune system to a wide variety of exogenous agents.However, low levels of BBB permeability and the BBB’s
transient increased permeability during systemic infections,
inﬂammations, transient hypertension, hypoxia, hyperther-
mia or acute stresses have been demonstrated in several
studies [13,15,16,28–32].
Apart from the possibility of direct viral- or bacterial-
induced impairment of the BBB, induction of inﬂammatory
cytokines (interleukin (IL)-17, interferon (IFN)-c, tumour
necrosis factor-alpha or IL-1beta) and metabolites (nitric
oxide (NO), platelet-activating factor and matrix metallo-
proteinases) during systemic infections or inﬂammations has
been identiﬁed to change the permeability of or break down
the BBB [28–35]. Transport of blood-borne inﬂammatory
cytokines (IL-1alpha, IL-1beta and tumour necrosis factor-
alpha) across the BBB has been shown to be one of the
possible mechanisms implicated in neurodegeneration and
then BBB leakage [30,36]. At least, transportation of IL-
1beta has been shown to be largely temperature dependent
in an in vitro model of the BBB [36,37]. Supporting
in vivo evidence is derived from the fact that hyperthermia
has demonstrated to exacerbate MS disease. The increased
temperature during exercise, inﬂammation or infection can
facilitate such transportation. Inﬂammatory cytokines can
alter BBB permeability both directly by interaction with
the BBB and indirectly by activation of microglial cells
[28,35,36].
As another possible pathway, the potent role of both
hypoxia and hyperthermia in occurrence of BBB leakage and
CNS vasogenic oedema has been recently highlighted [14–16].
The increased levels of inﬂammatory mediators (tumour necro-
sis-alpha, NO, superoxide dismutase, endothelin, glutathione
and malondialdehyde) have been identiﬁed as a consequence
responsible for the resultant increased BBB permeability to
IgG [15]. The responsibility of hypoxia for initial oligodendro-
cyte/myelin damage and the BBB breakdown in MS has been
illustrated well [38]. Furthermore, the ability of hyperthermia
to induce BBB breakdown (either directly or through altered
serotonin metabolism) and exacerbate MS disease has been
shown [12].
Alternatively, non-inﬂammatory-based mechanisms in-
volved in BBB leakage have been demonstrated. Extravasations
of blood-borne IgG through the BBB during adrenaline-
induced transient hypertension have been well shown [13].
However, transient hypertension mediated by drugs or other
exogenous and endogenous factors should be distinguished
from chronic systemic hypertension, especially regarding the
fact that due to self-reparative and compensative mechanisms
of the BBB, its transient permeability occurs temporarily only
in response to acute and sudden hypertension and not under
chronic conditions. Therefore, once or repeated over passing
of IgG through such transiently opened BBB may contribute
to CNS demyelination.
Recently, the increased BBB permeability after exposure
to acute stresses and even mobile microwave radiation has
been reported. Activation of brain mast cells and alterations
of tight junctions between the vascular endothelial cells have
been suggested as possible involved mechanisms, respectively
[34,39].
Transient BBB opening also has been observed after expo-
sure to ultrasound waves or by intracarotid infusion of
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Even though these strategies have been proposed in
patients with brain tumour to enhance delivery of antican-
cer drugs, viral vectors or nanoparticles, these seem to be
current risk factors in humans with certain diet regimens
(sugar-rich drinks) or environmental ultrasound stresses.
Massive or partial passing of IgG through such transient
opened BBB is likely.
Nonetheless, due to transient and accidental encounter
with some earlier-mentioned proposed risk factors (such as
drug-induced transient hypertension or exposure to ultra-
sound waves) and the necessity of co-presence of cross-
reactive immune responses, it seems rather difﬁcult to ﬁnd
the obvious supportive epidemiological data for their
participation in MS pathogenesis.
Moreover, the low but sustained efﬂux of long-term-gener-
ated cross-reactive IgG into intact BBB is the other possible
mechanism which may be involved in IgG deposition within
the CNS. Under physiological conditions, these CNS-accessed
IgGs may originate either from retrograde axonal transport of
IgGs from nerve terminals outside the CNS or via cerebrospi-
nal ﬂuid to brain tissue in BBB-absent regions [43,44].
However, entrance of myelin cross-reactive IgG into the
CNS can result in opsonisation of neuronal myelin sheaths.
These opsonised myelin sheaths trigger complement activation
and Fc-receptor-mediated phagocytosis, antibody-dependent
cell-mediated cytotoxicity (ADCC) and oxidative bursts in
microglial cells [45–49]. Continuous activation of microglial
cells leads to both gliosis and long-lasting secretion of inﬂam-
matory mediators (prostaglandin E2, NO and pro-inﬂamma-
tory cytokines, such as IL-1beta, IL-6 and tumour necrosis
factor-alpha) [45,46]. An inevitable consequence of such
CNS inﬂammation is a broken BBB, which recruits immune
cells [48]. Subsequently, cytotoxic and inﬂammatory responses
of CNS-inﬁltrated immune cells sustain the BBB breakdown
and CNS inﬂammation. Moreover, even Igs with cross-reactiv-
ity to other CNS antigens are thought to have the same po-
tency to break BBB after penetration into the CNS and
induce inﬂammation. Subsequently, recruitment of immune
cells into inﬂamed foci at the CNS can evoke immune re-
sponses against myelin antigens. This possibility may be the
main cause of absent antigenic mimicry with the known myelin
antigens (MBP, MOG and PLP) in MS patients with particu-
lar infection precedent.
In EAE, in an animal model of human MS disease, the
facilitative role of pertussis toxin in initiating disease onset
may be attributed to its robust potencies in induction of
IFN-c), IL-17 and NO and expansion of myelin-speciﬁc
antibodies (Th2 response) [29,50–52]. Therefore, crossing of
these expanded autoantibodies into IFN-c-, NO- and
IL-17-induced BBB leakage can lead to CNS inﬂammation
and disease onset.
Based on our proposed mechanism, a partial and tran-
sient increase in BBB permeability to cross-reactive IgG,
whether during systemic infections, inﬂammations, hypoxia,
hyperthermia, transient hypertension or acute stresses, is
required to trigger and initiate CNS inﬂammation.
Subsequently, inﬁltration of immune cells (T, B and
macrophages) will be a consequence of CNSinﬂammation-induced BBB breakdown. Similar to our pro-
posed mechanism for MS, in Batten disease, the juvenile
form of neuronal ceroid lipofscinosis (JNCL), the neurode-
generative role of CNS-accessed systemically produced
IgGs, has been shown to be preferred to late lymphocyte
inﬁltration [53]. Furthermore, the contribution of IgG leak-
age to neuronal dysfunction in drug-induced-refractory epi-
lepsies has been recently reported [54].
Conclusion
The possibility for the generation of myelin cross-reactive Igs
from peripheral B cells during exposure of immune system to
a wide variety of exogenous agents (virus, bacteria or allergen)
has clearly been demonstrated in several in vivo studies. More-
over, the intact or increased permeability of the BBB to IgG
during systemic infections, inﬂammations, transient hyperten-
sion, hypoxia and hyperthermia has been well shown. There-
fore, we proposed that the BBB-passed cross-reactive IgGs
via opsonisation of neuronal myelin sheath can trigger the
phagocytic pathway in recruited microglial cells. Excessive
activation of microglial cells by IgG-mediated cross-linking
of Fc-receptors can result in secretion of inﬂammatory media-
tors and then CNS inﬂammation. The disruption of BBB and
inﬁltration of immune cells will be an inevitable consequence
of such CNS inﬂammation.
Regarding the earlier-mentioned evidence, co-presence of
cross-reactive IgG and a BBB leakage provides an appropriate
predisposition to MS onset. Therefore, coincidence of cross-
reactive antibody responses and transient hypertension,
hypoxia, systemic inﬂammation or acute stresses can be
considered to be potent risk factors for MS.
Collectively, even though numerous risk factors have been
shown to affect BBB permeability and therefore occurrence
of BBB impairment seems to be likely over the human lifespan,
the rare frequency of MS may highlight the necessity of the
presence of at least a second cofactor. The second evidence
is derived from the fact that the BBB impairment does not nec-
essarily always lead to MS disease, and it is a common feature
of many neurodegenerative diseases. Furthermore, due to
quick, self-reparative potential of such affected BBB, the pres-
ence of high levels of an initiating factor to pass through per-
meable BBB and target CNS antigens is necessary. Circulating
autoreactive IgGs are strongly proposed to have enough po-
tential to improve these roles in MS pathogenesis even after
immediate BBB repair. Interestingly, predisposition of females
to produce more autoreactive Igs and their higher susceptibil-
ity to MS disease is completely inconsistent with the present
hypothesis.
In contrast to current proven belief that identiﬁes the bro-
ken–BBB-passed lymphocytes as the key initiator of disease
onset, the present hypothesis opens a new perspective towards
MS pathogenesis by introducing a possible linkage between
transient BBB leakage and cross-reactive IgG.
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First Question: What do we know already about the
subject?
The initiating factor in MS pathogenesis is not known
yet. However, in general, the broken BBB and subse-
quent inﬁltration of immune cells into the CNS have
been thought to be the main initiating event.
Second Question: What does your proposed theory add to
the current knowledge available, and what beneﬁts does it
have?
We propose that over passing of peripheral cross-reac-
tive IgG through the transiently permeable BBB during
systemic infections, inﬂammations, transient hyperten-
sion, hypoxia, hyperthermia or acute stresses may be
involved in BBB breakdown and initiation of MS
disease.
Third Question: Among numerous available studies, what
special further study is proposed for testing the idea?
MOG-primed sera or splenic MNCs’ culture superna-
tants obtained from EAE-established mice will be con-
centrated, puriﬁed for Igs and then biotin-labelled.
Healthy female C57Bl/6 mice aged 6–8-week will be
immunised with MOG-primed biotin-labelled Igs at sev-
eral time points. Simultaneously, at the same times, the
BBB can be left intact (as negative control) or perme-
abilisation of BBB will be performed by intra-peritoneal
(IP) administration of pertussis toxin or cocaine (as con-
trol), inﬂammatory cytokine-rich EAE serum (inﬂam-
mation), adrenaline (transient hypertension) or by
exposing the animal to hypobaric hypoxia (equivalent
to 0.5 atm) at 37 C (as hypoxia) in separate groups.
CNS tissues will be harvested from both EAE-estab-
lished- and non-affected mice. Using the avidin–biotin
cytochemical detection system, H&E and Luxol fast blue
staining methods, the inﬁltrated Igs, immune cells and
demyelinated region will be probed in sections.References
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